Navigation Links
Genomic Health Announces Eight Oncotype DX(R) Studies to Be Presented at 30th Annual San Antonio Breast Cancer Symposium
Date:12/7/2007

REDWOOD CITY, Calif., Dec. 7 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from eight studies of the company's Oncotype DX(R) breast cancer test are scheduled to be presented at the 30th Annual San Antonio Breast Cancer Symposium, taking place December 13-16, 2007. Oncotype DX is a multi-gene expression test that physicians use to predict the likelihood of recurrence and the likelihood of chemotherapy benefit for a large portion of early-stage breast cancer patients.

Following are details for each embargoed session (all times are Central Standard Time):

Thursday, Dec. 13, 2007, 9:15 to 9:30 a.m.

Abstract #10

Late-Breaking oral presentation: "Prognostic and predictive value of the

21-gene Recurrence Score assay in postmenopausal, node-positive, ER

positive breast cancer.

"Presenter: Kathy S. Albain, M.D.

Thursday, Dec. 13, 2007, 5 to 7 p.m.

Abstract #1043

Poster presentation: Recurrence Score by Oncotype DX evaluated on the

primary breast tumor predicts the 2-year survival after first relapse.

Presenter: Giampaolo Bianchini, M.D.

Abstract #1092

Poster presentation: "Prospective multi-center study of the impact of the

21-gene Recurrence Score assay on patient satisfaction, anxiety and

decisional conflict for adjuvant breast cancer treatment

selection.

"Presenter: Patricia B. Mumby, Ph.D.

Friday, Dec. 14, 7 to 9 a.m.

Abstract #2061

Poster presentation: "A retrospective analysis of the impact of Oncotype

DX low Recurrence Score results on treatment decisions in a single

academic breast cancer center.

"Presenter: Hongmei Lian
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. Personalized Medicine - The Genomic Revolution in Cardiac Care
4. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
5. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
6. Microarray Sequence Capture Speeds Large-Scale Resequencing of Targeted Genomic Regions
7. BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types
8. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
9. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
10. Tone Deafness Explained, from the Harvard Health Letter
11. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... NEW YORK und KISSING, Deutschland, ... ein Hersteller und Distributor eines computerunterstützten („robotischen") ... Nachum (Homi) Shamir , ein weltweit ... seines Leitungs- und Kontrollgremiums zum Unternehmen stößt. ... Shamir ist ein hochangesehener ...
(Date:7/31/2014)... July 31, 2014 Orexigen® Therapeutics, Inc. (Nasdaq: ... the second quarter 2014, on Thursday, August 7, 2014 ... a live webcast and conference call at 8:00 a.m. ... management will host the call and webcast to discuss ... may be accessed by calling (800) 708-4540 (domestic) or ...
(Date:7/31/2014)... 2014 Nutrastar International Inc. (OTCQB: NUIN; "Nutrastar" ... premium branded consumer products, including commercially cultivated Cordyceps Militaris ... announced the signing of its first distributor for its ... Hubei Province located ... . The contract with the ...
Breaking Medicine Technology:invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 2invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 3Orexigen Therapeutics to Host Second Quarter 2014 Financial Results Conference Call and Webcast 2Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 2Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 3Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 4
... and PARIS, Feb. 24, 2011 /PRNewswire-Asia-FirstCall/ -- Sanofi-aventis (EURONEXT: ... it has completed the previously announced acquisition of BMP ... stockholders held today, BMP Sunstone stockholders approved the adoption ... Star 2010, Inc., a wholly owned subsidiary of sanofi-aventis, ...
... Conn., Feb. 24, 2011 Mira Dx announced today that ... acceptance of a pivotal breast cancer study in the January ... BRCA1 coding sequence mutations are associated with breast ... less than 5% of breast cancer risk. The research identified ...
Cached Medicine Technology:Sanofi-Aventis Announces Approval and Closing of BMP Sunstone Acquisition Creating a Strong Consumer Health Care Platform in China 2Mira Dx Licenses Triple Negative Breast Cancer Risk Variant from Yale University 2
(Date:7/31/2014)... 31, 2014 LDM Global ( http://www.ldmglobal.com ... model that is simplified and predictable with fixed fees ... As a leading international provider of legal discovery management ... has become glaringly apparent that both the courts and ... budgets and the complex pricing structure that plagues the ...
(Date:7/31/2014)... 2014 (HealthDay News) -- With the World Health Organization ... Ebola outbreak has risen to 729, the U.S. ... a travel warning for,the region. The "Level 3 ... affected countries -- Guinea, Liberia and Sierra Leone -- ... is worsening in West Africa," CDC Director Dr. Tom ...
(Date:7/31/2014)... 31, 2014 Setting goals for a fitness ... on successful tips to weight loss. Fitness on the Go ... 8 years, and has worked with 6000 customers on an ... had the chance to monitor why customers start exercising with ... long they stick to their program, whether or not they ...
(Date:7/31/2014)... The VitalSleep anti snoring device is a mandibular advancement splint that ... airway to quiet snoring. , Dawn M. of Utah shared ... husband by allowing them to share the same bedroom again. ... 15 years ago and I remember nights when it was so ... to head downstairs for any relief. As the years have gone ...
(Date:7/31/2014)... York, New York (PRWEB) July 31, 2014 ... to grow, as Bernstein Liebhard LLP notes that ... that it plans to voluntarily remove its power ... to a report from Bloomberg.com, the company said ... and benefits associated with the devices remain uncertain.* ...
Breaking Medicine News(10 mins):Health News:LDM Global Announces Predictable Simple Fixed-Fee Pricing 2Health News:CDC Issues Travel Warning as West Africa Ebola Outbreak Worsens 2Health News:Fitness on the Go's Rewards Program Helps Clients Reach Their Goals 2Health News:New Snoring Mouthpiece Reviews from VitalSleep 2Health News:Uterine Morcellation Controversy Grows, as Bernstein Liebhard LLP Notes Johnson & Johnson Decision to Withdraw Power Morcellators from Market 2Health News:Uterine Morcellation Controversy Grows, as Bernstein Liebhard LLP Notes Johnson & Johnson Decision to Withdraw Power Morcellators from Market 3
... pills and capsules that show a tendency in the standard ... a faster and potentially unsafe manner in patients who have ... proven safe with testing in people. That,s the conclusion ... of ACS, Molecular Pharmaceutics , a bi-monthly journal. ...
... WASHINGTON, Sept. 23 In the year since the crash ... concerns despite rising unemployment levels and ongoing economic uncertainty, according to ... In a poll surveying 2,160 adults conducted by Harris Interactive(R) between ... the economy caused stress in their lives, down from 82 percent ...
... , PRINCETON, N.J., Sept. 23 Bringing a new ... makers of Trojan(R) Brand Condoms recently introduced Trojan 2GO(R), a new ... new product, which is designed to stand-up to purses, wallets, pockets ... food, drug and convenience retail locations, making Trojan 2GO both easy ...
... NORTHRIDGE, Calif., Sept. 23 Today, Nature Made(R) ... Greatness(TM) contest. Nature Made is the nation,s best-selling brand ... mass and club channels. The company celebrates the inherent greatness ... challenged Americans to submit their personal stories of greatness as ...
... cyber-bullying and an increase in violence among young women will ... Professor Kerry Carrington, head of Queensland University of Technology,s School ... confirm, contrary to general academic opinion, young women are fast ... will present her findings, to be revealed in her book ...
... Mich. Immune therapies have been explored as a way ... from the University of Michigan Comprehensive Cancer Center suggests that ... critical immune system cells. The study was done ... in the lab before being available for humans. But the ...
Cached Medicine News:Health News:Interview Alert: At Anniversary of Financial Meltdown, Psychologists Notice Downward Trends in Economic Stress 2Health News:Makers of Trojan(R) Brand Condoms Introduce Trojan 2GO(R), a Unique, Portable, Protective and Discreet Packaging for Condoms 2Health News:Makers of Trojan(R) Brand Condoms Introduce Trojan 2GO(R), a Unique, Portable, Protective and Discreet Packaging for Condoms 3Health News:Makers of Trojan(R) Brand Condoms Introduce Trojan 2GO(R), a Unique, Portable, Protective and Discreet Packaging for Condoms 4Health News:National 'Greatness' Contest Winners Announced 2Health News:National 'Greatness' Contest Winners Announced 3Health News:Girls' violence on the rise 2Health News:Study looks at using the immune system to reduce prostate cancer risk 2
HbA1c / HbCalibrator...
Control Plasma for Assays of Low MolecularWeight Heparins (LMWH) using Anti-Xa Method on STA© Analyzers....
... Abnormal Control Plasmas for ... D-dimer and Free Protein ... For use with STA© ... D-DI (#0515) andSTA© LIATEST© ...
CRP Full Range (0.1-160mg/l)...
Medicine Products: